Finding the best effective way of treatment for rapid I-131 turnover Graves’ disease patients: A randomized clinical trial
Conclusions:
Treatment of rapid turnover Graves’ disease patients with high dose I-131 (7.4 MBq/g) provides significantly higher cure rates at 12 months, and 3 times odds of cure than 3.7 MBq/g I-131 plus LiCO3 with lesser side effects. We thus recommend 7.4 MBq I-131/g for treatment in these patients.
Source: Medicine - Category: Internal Medicine Tags: Research Article: Clinical Trial/Experimental Study Source Type: research
More News: Clinical Trials | Hypothyroidism | Internal Medicine | Iodine | Lithium | Lithium Carbonate | Statistics | Study | Thyroid